These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 16292494)

  • 1. Tenascin-C protein is induced by transforming growth factor-beta1 but does not correlate with time to tumor progression in high-grade gliomas.
    Hau P; Kunz-Schughart LA; Rümmele P; Arslan F; Dörfelt A; Koch H; Lohmeier A; Hirschmann B; Müller A; Bogdahn U; Bosserhoff AK
    J Neurooncol; 2006 Mar; 77(1):1-7. PubMed ID: 16292494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression levels of melanoma inhibitory activity correlate with time to progression in patients with high-grade glioma.
    Hau P; Ruemmele P; Kunz-Schughart LA; Doerfelt A; Hirschmann B; Lohmeier A; Koch H; Mueller A; Bogdahn U; Bosserhoff AK
    Oncol Rep; 2004 Dec; 12(6):1355-64. PubMed ID: 15547763
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation of thrombospondin-1 and transforming growth factor-beta expression with malignancy of glioma.
    Kawataki T; Naganuma H; Sasaki A; Yoshikawa H; Tasaka K; Nukui H
    Neuropathology; 2000 Sep; 20(3):161-9. PubMed ID: 11132930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor Grade versus Expression of Invasion-Related Molecules in Astrocytoma.
    Virga J; Bognár L; Hortobágyi T; Zahuczky G; Csősz É; Kalló G; Tóth J; Hutóczki G; Reményi-Puskár J; Steiner L; Klekner A
    Pathol Oncol Res; 2018 Jan; 24(1):35-43. PubMed ID: 28161812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous expression of transforming growth factor beta1 inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model.
    Ashley DM; Kong FM; Bigner DD; Hale LP
    Cancer Res; 1998 Jan; 58(2):302-9. PubMed ID: 9443409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tenascin-C upregulates matrix metalloproteinase-9 in breast cancer cells: direct and synergistic effects with transforming growth factor beta1.
    Kalembeyi I; Inada H; Nishiura R; Imanaka-Yoshida K; Sakakura T; Yoshida T
    Int J Cancer; 2003 May; 105(1):53-60. PubMed ID: 12672030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transforming growth factor-β pathway activity in glioblastoma.
    Frei K; Gramatzki D; Tritschler I; Schroeder JJ; Espinoza L; Rushing EJ; Weller M
    Oncotarget; 2015 Mar; 6(8):5963-77. PubMed ID: 25849941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of CCAAT/enhancer binding protein beta correlates with prognosis in glioma patients.
    Homma J; Yamanaka R; Yajima N; Tsuchiya N; Genkai N; Sano M; Tanaka R
    Oncol Rep; 2006 Mar; 15(3):595-601. PubMed ID: 16465418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of a restrictive receptor for interleukin 13 is associated with glial transformation.
    Debinski W; Slagle B; Gibo DM; Powers SK; Gillespie GY
    J Neurooncol; 2000 Jun; 48(2):103-11. PubMed ID: 11083073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Relationship of bcl-2 gene expression with cell proliferation and apoptosis in human gliomas].
    Yu S; Pu P; Jiang D; An T; Guan X; Yang L
    Zhonghua Bing Li Xue Za Zhi; 2000 Feb; 29(1):12-5. PubMed ID: 11866884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.
    Esposito I; Penzel R; Chaib-Harrireche M; Barcena U; Bergmann F; Riedl S; Kayed H; Giese N; Kleeff J; Friess H; Schirmacher P
    J Pathol; 2006 Apr; 208(5):673-85. PubMed ID: 16450333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Correlation between TGF- β1 expression and Treg cell infiltration in glioma].
    Zhang GH; Jiang XB; Zhang XH; Sai K; Yang QY; Chen ZP; Mou YG
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jun; 27(6):680-2. PubMed ID: 21882476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in glioblastoma and immunohistochemical evaluation of IGFBP-2 and CDC20.
    Marucci G; Morandi L; Magrini E; Farnedi A; Franceschi E; Miglio R; Calò D; Pession A; Foschini MP; Eusebi V
    Virchows Arch; 2008 Dec; 453(6):599-609. PubMed ID: 18953566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Degradation of extracellular matrix protein tenascin-C by cathepsin B: an interaction involved in the progression of gliomas.
    Mai J; Sameni M; Mikkelsen T; Sloane BF
    Biol Chem; 2002 Sep; 383(9):1407-13. PubMed ID: 12437133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical impact and functional aspects of tenascin-C expression during glioma progression.
    Herold-Mende C; Mueller MM; Bonsanto MM; Schmitt HP; Kunze S; Steiner HH
    Int J Cancer; 2002 Mar; 98(3):362-9. PubMed ID: 11920587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TGF-β1 regulating miR-205/miR-195 expression affects the TGF-β signal pathway by respectively targeting SMAD2/SMAD7.
    Duan Y; Chen Q
    Oncol Rep; 2016 Oct; 36(4):1837-44. PubMed ID: 27574009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of TGF-beta activity by latent TGF-beta-binding protein 1 in human malignant glioma cells.
    Tritschler I; Gramatzki D; Capper D; Mittelbronn M; Meyermann R; Saharinen J; Wick W; Keski-Oja J; Weller M
    Int J Cancer; 2009 Aug; 125(3):530-40. PubMed ID: 19431147
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HSP47 Promotes Glioblastoma Stemlike Cell Survival by Modulating Tumor Microenvironment Extracellular Matrix through TGF-β Pathway.
    Jiang X; Zhou T; Wang Z; Qi B; Xia H
    ACS Chem Neurosci; 2017 Jan; 8(1):128-134. PubMed ID: 27696866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of the Ets-1 transcription factor in human astrocytomas is associated with Fms-like tyrosine kinase-1 (Flt-1)/vascular endothelial growth factor receptor-1 synthesis and neoangiogenesis.
    Valter MM; Hügel A; Huang HJ; Cavenee WK; Wiestler OD; Pietsch T; Wernert N
    Cancer Res; 1999 Nov; 59(21):5608-14. PubMed ID: 10554042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.